Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tommie Reerink's Stock Ratings
Goldman Sachs Analyst
Tommie Reerink is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/20/2025
Overall Average Return
0.56%
Smart Score
Overall Average Return Percentile
39th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | ATRA | Buy Now | Atara Biotherapeutics | $7.60 | 44.74% | Tommie Reerink44% | $12.5 → $11 | Maintains | Sell | Get Alert |
| 11/10/2023 | ATRA | Buy Now | Atara Biotherapeutics | $7.60 | -93.42% | Tommie Reerink44% | $3 → $0.5 | Maintains | Sell | Get Alert |
| 08/09/2022 | ATRA | Buy Now | Atara Biotherapeutics | $7.60 | -60.53% | Tommie Reerink44% | $4 → $3 | Maintains | Sell | Get Alert |
